• Economy
  • Editor’s Pick
Money Rise Today – Investing and Stock News
  • Investing
  • Stock
Investing

Nvidia stock plunges after Intel’s 18A move: what does it mean for AI chips?

by December 25, 2025
written by December 25, 2025

Nvidia stock (NASDAQ: NVDA) tumbled nearly 1% on Wednesday after reports surfaced that the AI chipmaker has paused testing of Intel’s ambitious 18A manufacturing process.

The move marks a significant setback for Intel’s foundry revival strategy and reinforces questions about whether the chip giant can compete with Taiwan Semiconductor Manufacturing Company (TSMC).

Both Nvidia and Broadcom had been evaluating Intel’s 18A node over recent months, but the tests have stalled as performance and yield targets fell short of expectations.​

What the 18A pause means for Nvidia’s supply chain

Intel’s 18A process promised significant improvements over its previous generation: 30% higher transistor density, 25% faster performance at the same voltage, and up to 36% lower power consumption for equivalent throughput.

These specs matter because every watt saved translates to lower data center cooling bills, and every percentage point of density improvement means more AI compute per chip die.

Broadcom and Nvidia spent months running qualification tests, essentially manufacturing small batches of experimental chips to see how the new process would perform in the real world.​

The pause signals that those prototype runs didn’t deliver the goods.

When chip designers pull back from testing, it rarely means outright rejection.

Instead, it reflects either yield problems, performance shortfalls, or architectural mismatches that require more development time.

Broadcom had already flagged concerns, reportedly telling Intel engineers that 18A was “not currently viable for high-volume production” back in September.

Nvidia’s pause suggests similar issues remain unresolved.

For Nvidia, this is especially notable because the company operates on razor-thin timelines; new AI accelerators must launch on schedule or risk losing market share to competitors.

Sticking with proven TSMC capacity is the safer play.​

Intel emphasized that 18A remains “on track,” but the reality is blunt: a pause from Nvidia, the world’s most influential chip customer, reads as a vote of no confidence.

Competing against a foundry that already has 72% market share and a 41% revenue surge in Q3 2025 requires flawless execution.

Intel has already pushed back the 18A timeline twice, first to 2026, then to mid-2026 due to IP qualification delays, and customer hesitation only compounds the delays.​

Nvidia stock: Does this reshape the AI foundry map?

This development actually reinforces TSMC’s near-total dominance of advanced chip manufacturing.

The Taiwanese foundry controls nearly three-quarters of the market and is shipping the 3nm process at scale while maintaining 90% yields.

Samsung, Intel’s closest competitor, remains stuck with yield challenges of its own, even as it pushes its 2nm GAA (Gate-All-Around) technology.

For Nvidia and Broadcom, the path of least resistance is clear: keep working with TSMC.​

The Nvidia partnership announced in September 2025, which included a $5 billion investment by Nvidia, was supposed to be that breakthrough moment.

But the deal carefully avoided any manufacturing commitments. Nvidia CEO Jensen Huang explicitly stated the company would continue relying on TSMC. The 18A pause confirms that reality.​

For markets, uncertainty carries a heavier tax than bad news.

Intel shares fell 2-3% early Wednesday on the report. Nvidia, too, witnessed some correction, a sign that traders have already priced in the company’s dependence on TSMC.

Analysts like Angelo Zino from CFRA have warned that Intel’s foundry business will “continue to bleed cash at least through 2027,” while Samsung and TSMC will capture the lion’s share of AI chip production capacity.​

The post Nvidia stock plunges after Intel’s 18A move: what does it mean for AI chips? appeared first on Invezz

0 comment
0
FacebookTwitterPinterestEmail

previous post
Commodity wrap: gold, silver prices ease on Christmas Eve; oil heads for steepest drop since 2020
next post
Agios Pharma jumps 15% as FDA expands use of anaemia drug mitapivat

related articles

US stocks open in the red: S&P down...

January 15, 2026

Bank of America Q4 beat estimates, but here’s...

January 15, 2026

Copper, aluminum climb on supply worries, but Commerzbank...

January 15, 2026

Why Nvidia stock is down over 2% today

January 15, 2026

Climate activists press BP, Shell on post-peak oil...

January 15, 2026

Brazil’s Ibovespa rises on polls and US data...

January 15, 2026

Europe bulletin: BoE targets non-bank risks, Arctic tensions...

January 15, 2026

Why is Netflix considering going all-cash for WBD...

January 15, 2026

Why is AppLovin stock crashing despite a new...

January 15, 2026

Evening digest: Bitcoin breaks $95K, Iran threatens US...

January 15, 2026
Enter Your Information Below To Receive Free Trading Ideas, Latest News, And Articles.


Your information is secure and your privacy is protected. By opting in you agree to receive emails from us. Remember that you can opt-out any time, we hate spam too!

Latest News

  • Trump hits EU for lack of Gaza aid, says Israel needs to ‘make a decision’ with Hamas not releasing hostages

    July 27, 2025
  • Trump’s surgeon general pick touted as ‘fierce’ MAHA advocate before confirmation hearing

    May 2, 2025
  • Did China really dominate tech in 2025? Why Xi’s victory lap may be premature

    January 3, 2026
  • Kamala stays on offense, Trump went to personal attacks, ABC much tougher on former president

    September 11, 2024
  • Schumer forces name change for ‘big, beautiful bill’ moments before it passes

    July 1, 2025

Popular Posts

  • 1

    Secret Service admits leaning on ‘state and local partners’ after claim it ignored Trump team’s past requests

    July 21, 2024
  • 2

    District judges’ orders blocking Trump agenda face hearing in top Senate committee

    April 2, 2025
  • 3

    Five more House Democrats call on Biden to drop out, third US senator

    July 19, 2024
  • 4

    Forex Profit Calculator: Maximize Your Trading Potential

    July 10, 2024
  • 5

    Elon and Vivek should tackle US funding for this boondoogle organization and score a multimillion dollar win

    December 4, 2024

Categories

  • Economy (829)
  • Editor's Pick (7,479)
  • Investing (824)
  • Stock (965)

Latest Posts

  • Longtime Joe Biden aide to appear under subpoena after Jill’s ‘work husband’ pleads Fifth

    July 18, 2025
  • Trump administration takes hard line on Haitian violence, labels gangs foreign terrorist organizations

    May 3, 2025
  • ‘Draconian’ and dangerous: Former Trump nat sec advisor sounds alarm on Biden-era DOJ’s plans for Google

    May 1, 2025

Recent Posts

  • Bitcoin mining company Cipher considering sale after takeover bid

    July 18, 2024
  • Trump asks SCOTUS to uphold freeze on billions in USAID payments

    August 27, 2025
  • Biden calls for Supreme Court term limits, code of conduct, limits on presidential immunity

    July 29, 2024

Editor’s Pick

  • How the White House turkey pardon became an American tradition

    November 27, 2025
  • Trump says he believes Hegseth ‘100%’ on Venezuelan drug boat strike denial amid allegations

    December 1, 2025
  • LEE ZELDIN: Why we’re shutting down Biden’s EPA museum

    March 31, 2025
  • About us
  • Contacts
  • Privacy Policy
  • Terms & Conditions

Disclaimer: moneyrisetoday.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

Copyright © 2025 moneyrisetoday.com | All Rights Reserved

Money Rise Today – Investing and Stock News
  • Economy
  • Editor’s Pick
Money Rise Today – Investing and Stock News
  • Investing
  • Stock